News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotechs are Back in Favor Amid Plethora of Positive Developments


9/24/2013 8:20:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

It isn’t often that the biotechnology industry gets swamped with plenty of good news, but that’s what has been happening in recent months. Not surprisingly, they have attracted investor interest. A number of new drug approvals, affirmative data, and accelerated sales and earnings growth at the big biotech companies have re-focused attention to the industry. And increased activity in mergers-and-acquisition front has added to the sector’s allure. A robust M&A environment, a key ingredient for a sustainable biotech bull market rally, has helped drive up the price of many biotech stocks.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES